Search for other papers by Lukas Plachy in
Google Scholar
PubMed
Search for other papers by Petra Dusatkova in
Google Scholar
PubMed
Search for other papers by Klara Maratova in
Google Scholar
PubMed
Search for other papers by Shenali Anne Amaratunga in
Google Scholar
PubMed
Search for other papers by Dana Zemkova in
Google Scholar
PubMed
Search for other papers by Vit Neuman in
Google Scholar
PubMed
Search for other papers by Stanislava Kolouskova in
Google Scholar
PubMed
Search for other papers by Barbora Obermannova in
Google Scholar
PubMed
Search for other papers by Marta Snajderova in
Google Scholar
PubMed
Search for other papers by Zdenek Sumnik in
Google Scholar
PubMed
Search for other papers by Jan Lebl in
Google Scholar
PubMed
Search for other papers by Stepanka Pruhova in
Google Scholar
PubMed
.d. (−2.1 to −1.7 s.d. ). The average maximum stimulated GH concentration of the study cohort was 1.4 μg/L (0.6–3.4 μg/L). Thirty children had central adrenal insufficiency, 27 had central hypothyroidism, ten had hypogonadotropic hypogonadism, and three
Search for other papers by Christine Poitou in
Google Scholar
PubMed
Search for other papers by Anthony Holland in
Google Scholar
PubMed
Search for other papers by Charlotte Höybye in
Google Scholar
PubMed
Search for other papers by Laura C G de Graaff in
Google Scholar
PubMed
Search for other papers by Sandrine Bottius in
Google Scholar
PubMed
Search for other papers by Berit Otterlei in
Google Scholar
PubMed
Search for other papers by Maithé Tauber in
Google Scholar
PubMed
. Hypogonadism was present in 98% of males and 94% of females. Both primary and central hypogonadism were present, as well as mixed forms. The major reason why individuals did not receive (adequate doses of) SHRT was for behavioral challenges. Based on our
Search for other papers by Milou Cecilia Madsen in
Google Scholar
PubMed
Search for other papers by Martin den Heijer in
Google Scholar
PubMed
Search for other papers by Claudia Pees in
Google Scholar
PubMed
Search for other papers by Nienke R Biermasz in
Google Scholar
PubMed
Search for other papers by Leontine E H Bakker in
Google Scholar
PubMed
concentrations in males can lead to a clinical syndrome known as male hypogonadism. This can be caused by testicular disease (primary hypogonadism) or central, pituitary, or hypothalamic disease (secondary hypogonadism). Causes can be genetic, like in Klinefelter
Search for other papers by Rebeca Esquivel-Zuniga in
Google Scholar
PubMed
Search for other papers by Alan D Rogol in
Google Scholar
PubMed
failure or the inability to synthesize or respond to sex steroids; (2) permanent hypogonadotropic hypogonadism, characterized by low levels of FSH and LH and can be caused by an abnormality in the central nervous system (CNS) or can be associated with
Search for other papers by Rui-yi Tang in
Google Scholar
PubMed
Search for other papers by Rong Chen in
Google Scholar
PubMed
Search for other papers by Miao Ma in
Google Scholar
PubMed
Search for other papers by Shou-qing Lin in
Google Scholar
PubMed
Search for other papers by Yi-wen Zhang in
Google Scholar
PubMed
Search for other papers by Ya-ping Wang in
Google Scholar
PubMed
M Libri DV Guizzardi F Guarducci E Maiolo E Pignatti E Asci R Persani L. New understandings of the genetic basis of isolated idiopathic central hypogonadism . Asian Journal of Andrology 2012 14 49 – 56 . ( doi:10
Search for other papers by Mikkel Andreassen in
Google Scholar
PubMed
Search for other papers by Anders Juul in
Google Scholar
PubMed
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
Search for other papers by Niels Jørgensen in
Google Scholar
PubMed
, we observed an abnormal relationship between total-testosterone and cfT vs the corresponding LH in the majority of patients. Thus, we speculate that the bioactivity of LH might be reduced in male patients with central hypogonadism. This is to our
Search for other papers by Amar Osmancevic in
Google Scholar
PubMed
Search for other papers by Kristin Ottarsdottir in
Google Scholar
PubMed
Search for other papers by Margareta Hellgren in
Google Scholar
PubMed
Search for other papers by Ulf Lindblad in
Google Scholar
PubMed
Search for other papers by Bledar Daka in
Google Scholar
PubMed
hypogonadic levels in adulthood, this is defined as late-onset hypogonadism (LOH), according to the European Association of Urology (EAU) ( 5 ). EAU guidelines from 2019/2021 and Swedish National Guidelines consider male hypogonadism to be defined as an
Search for other papers by Shruti Khare in
Google Scholar
PubMed
Search for other papers by Anurag R Lila in
Google Scholar
PubMed
Search for other papers by Hiren Patt in
Google Scholar
PubMed
Search for other papers by Chaitanya Yerawar in
Google Scholar
PubMed
Search for other papers by Manjunath Goroshi in
Google Scholar
PubMed
Search for other papers by Tushar Bandgar in
Google Scholar
PubMed
Search for other papers by Nalini S Shah in
Google Scholar
PubMed
(3094.36±6863.01 vs 7927.07±16 748.10 ng/ml) as compared to males ( P <0.001). Baseline biochemical gonadal axis evaluation was available in 72.72% ( n =32/44 males) and all of them had secondary hypogonadism. Central hypothyroidism was seen in three
Search for other papers by Yijun Tang in
Google Scholar
PubMed
Search for other papers by Yao Chen in
Google Scholar
PubMed
Search for other papers by Jiayi Wang in
Google Scholar
PubMed
Search for other papers by Qianwen Zhang in
Google Scholar
PubMed
Search for other papers by Yirou Wang in
Google Scholar
PubMed
Search for other papers by Yufei Xu in
Google Scholar
PubMed
Search for other papers by Xin Li in
Google Scholar
PubMed
Search for other papers by Jian Wang in
Google Scholar
PubMed
Search for other papers by Xiumin Wang in
Google Scholar
PubMed
the phenotype and genotype in the subjects who were diagnosed both clinically and genetically (NGS-positive group, n = 64). Furthermore, subjects were divided into the primary gonadal/genital disorders group ( n = 48) and central hypogonadism group
Search for other papers by Giuseppe Grande in
Google Scholar
PubMed
Search for other papers by Andrea Graziani in
Google Scholar
PubMed
Search for other papers by Antonella Di Mambro in
Google Scholar
PubMed
Search for other papers by Riccardo Selice in
Google Scholar
PubMed
Department of Medicine, University of Padova, Padova, Italy
Search for other papers by Alberto Ferlin in
Google Scholar
PubMed
Bonomi M & Chiodini I . FSH and bone: comparison between males with central versus primary hypogonadism . Frontiers in Endocrinology 2022 13 939897 . ( https://doi.org/10.3389/fendo.2022.939897 ) 81 Iitsuka Y Bock A Nguyen DD Samango